Skip to main content
Log in

Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The most common malignancy in men worldwide is cancer of the prostate. Androgens play a direct role in normal and malignant growth of prostate cells via the androgen receptor (AR). This study analyzed the polymorphic CAG repeat sequence in exon 1 of the AR gene to determine if the number of repeats might be an indicator of prostate cancer risk or aggressive disease. DNA was extracted from blood samples of 20 black and 20 white men with well-documented prostate cancer and 40 healthy, controls (20 blacks and 20 whites). PCR amplifications was followed by gel electrophoresis and DNA sequencing. This region normally contains between 9 and 29 repeats. Patients and controls both had minor variations in the number of repeats, which ranged from 13 to 27 with 21 being the most frequent allele. Black controls and patients both had a mean of 20±3, repeats; in whites the mean was significantly lower in patients than controls (21±2 versus 23±2; p=0.004). Combined black and white patients also had a lower number than the combined group of controls (20±3 versus 22±3; p=0.02). Similarly, black and white patients with aggressive disease has a lower number than patients whose disease was more slowly progressive (19±2 versus 22±3; p=0.02). We conclude that the small differences in the number of CAG repeats in both black and white patients do not appear to be a strong indicator of risk or aggressive disease but that this size polymorphism may be one of many genetic and environmental risk factors involved in prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. (1999). Ca. J. Clin. 49, 8–31.

    Article  CAS  Google Scholar 

  2. Black, R. J., Bray, F., Ferlay, J., and Parkin, D. M. (1997). Eur. J. Cancer 73, 1075–1107.

    Article  Google Scholar 

  3. Sitas, F., Madhoo, J., and Wessie, J. (1998). In Natl. Ca. Reg. SA, pp. 24.

  4. Muir, C., Waterhouse, J., Mack, T., Powell, J., and Whelan, S., (eds). (1987). Lyon, France: IARC Press

    Google Scholar 

  5. Coetzee, G. A. and Ross, R. K. (1994). J. Natl. Can. Inst. 86, 872–873.

    Article  CAS  Google Scholar 

  6. Ross, R. K., Coetzee, G. A., Pearce, C. L., et al. (1999). Eur. Urol. 35, 355–361.

    Article  PubMed  CAS  Google Scholar 

  7. Jenster, G., Van der Korput, H. G. A. M., Van Vroonhoven, C., Van der Kwast T. H., Trapman, J., and Brinkman, A. O. (1991). Mol. Endocrinol. 5, 1396–1404.

    Article  PubMed  CAS  Google Scholar 

  8. Edwards, A., Hammond, H. A., Jin, L., Caskey, C. T., and Chakraboty, R. (1992). Genomics 12, 241–253.

    Article  PubMed  CAS  Google Scholar 

  9. Chamberlain, N. L., Driver, E. D., and Miesfield, R. L. (1994). Nucl. Acids. Res. 22, 3181–3186.

    Article  PubMed  CAS  Google Scholar 

  10. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. (1991). Nature 352, 77–79.

    Article  PubMed  Google Scholar 

  11. Giovannucci, E., Stampfer, M. J., Krithivas, K., et al. (1997). Proc. Natl. Acad. Sci. USA 94, 3320–3323.

    Article  PubMed  CAS  Google Scholar 

  12. Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., and Henderson, B. E. (1995). Cancer Supplement 75, 1778–1782.

    Google Scholar 

  13. Stanford, J. L., Just, J. J., Gibbs, M., et al. (1997). Cancer Res. 57, 1194–1198.

    PubMed  CAS  Google Scholar 

  14. Mhatre, A. N., Trifiro, M. A., Kaufman, M., et al. (1993). Nature Genetics 5, 184–188.

    Article  PubMed  CAS  Google Scholar 

  15. Irvine, R. A., Yu, M. C., Ross, R. K., and Coetzee, G. A. (1995). Cancer Res. 55, 1937–1940.

    PubMed  CAS  Google Scholar 

  16. Ribiero, M., Ruff, P., and Falkson, G. (1997). Am. J. Clin. Oncol., 20, 605–608.

    Article  Google Scholar 

  17. Bratt, O., Borg, A., Kristoffersson, U., Lundgren, R., Zhang, Q. X., and Olsson, H. (1999). Br. J. Cancer 81, 672–676.

    Article  PubMed  CAS  Google Scholar 

  18. Rosenthal, M. A. (2000). Aus. N. Z. J. Med. 30, 593–598.

    CAS  Google Scholar 

  19. Ruijter, E., van de Kaa, C., Miller, G., Ruiter, D., Debruyne, F., and Schalken, J. (1999). Endo. Rev. 20, 22–45.

    Article  CAS  Google Scholar 

  20. Makridakis, N. M., Ross, R. K., Pike, M. C., et al. (1999). Lancet 354, 975–978.

    Article  PubMed  CAS  Google Scholar 

  21. Gottlieb, B., Trifiro, M., Lumbroso, R., and Pinsky, L. (1997). Nucl. Acids Res. 25, 158–162.

    Article  PubMed  CAS  Google Scholar 

  22. Selley, S., Donovan, J., Faulkner, A., Coast, J., and Gillat, D. (1997). Health Tech. Assess. 1, 1–72.

    Google Scholar 

  23. Cummings J. H. and Bingham, S. A. (1998). Br. Med. J. 317, 1636–1640.

    CAS  Google Scholar 

  24. Marcelli, M. and Cuningham, G. R. (1999). J. Clin. Endocrinol. Metab. 84, 3463–3468.

    Article  PubMed  CAS  Google Scholar 

  25. Walker, A. R. P., Walker, B. F., Tsetetsi, N. G., Sibetso, C., Siwedi, D., and Walker, A. J. (1992). Br. J. Cancer. 65, 438–441.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vanessa R. Panz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panz, V.R., Joffe, B.I., Haffejee, M. et al. Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men. Endocr 15, 213–216 (2001). https://doi.org/10.1385/ENDO:15:2:213

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:15:2:213

Key Words

Navigation